Last update 01 Nov 2024
Alexion Pharma International Operations Ltd.
Subsidiary Company|
Ireland
Last update 01 Nov 2024
Overview
Tags
Other Diseases
Immune System Diseases
Hemic and Lymphatic Diseases
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
一项在中国阵发性睡眠性血红蛋白尿症（PNH）补体抑制剂初治成人受试者中评价ravulizumab的有效性、安全性、药代动力学、药效学和免疫原性的III期、单臂、开放标签、多中心研究
[Translation] A phase III, single-arm, open-label, multicenter study to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of ravulizumab in Chinese adults with paroxysmal nocturnal hemoglobinuria (PNH) who are complement inhibitor-naive
一项评估ALXN1850（重组碱性磷酸酶）在既往未接受过Asfotase Alfa治疗的患有低磷酸酯酶症的青少年（≥12岁至<18岁 ）和成年受试者中皮下给药的有效性和安全性的随机、双盲、安慰剂对照、多中心、III期研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter, Phase III study to evaluate the efficacy and safety of ALXN1850 (recombinant alkaline phosphatase) administered subcutaneously in adolescents (≥12 years to <18 years) and adults with hypophosphatasia who have not been previously treated with Asfotase Alfa
一项在IgA肾病（IgAN）成人受试者中评价Ravulizumab的有效性和安全性的III期、随机、双盲、安慰剂对照研究
[Translation] A Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Ravulizumab in adult subjects with IgA nephropathy (IgAN)
100 Clinical Results associated with Alexion Pharma International Operations Ltd.
Login to view more data
Login to view more data
100 Deals associated with Alexion Pharma International Operations Ltd.
Login to view more data
100 Translational Medicine associated with Alexion Pharma International Operations Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 15 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
NDA/BLA
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free